pt
bottom line report except result
repres market leadership broad product portfolio continu
take share expect zebra abl best organ
revenu growth near futur remain sever catalyst place
drive zebra toward continu top line growth oper
manufactur scale lower interest expens drive ep growth
transport logist manufactur custom
begin transit android oper system provid new
catalyst zebra
zebra report revenu billion repres organ growth
acceler seen revenu beat consensu
expect billion estim billion ep
beat consensu expect
adjust ebitda margin robust adj ebitda margin grew
basi point basi point base oper
evm segment grow organ evm segment grew excess
alreadi high expect primari reason quarter
segment sale grow organ compar
guidanc impress still conserv manag
point revenu growth reason view
howev ep point adjust ebitda margin
believ basi point upsid manag ebitda
maintain revenu estim billion growth
rais ep estim adjust ebitda
margin increas ep estim
revenu estim billion billion
technolog hardwar equip
total debt total asset
share year revenu growth
like peak quarter expect remain least histor
averag even tough comparison zebra earn power still
gain momentum result oper scale manufactur effeci
lower interest cost strongli reiter buy rate urg investor
add posit level rais price target
maintain ntm price-to-earnings multipl use ep estim
believ fair valuat zebra share ntm price-to-earnings
import pleas read disclosur disclaim page report
blow-out result buy rate report anoth quarter acceler
growth ep crush consensu estim total report growth
organ growth account xplore technolog acquisit fx benefit
enterpris visibl mobil evm segment grew organ year-over-year asset
achiev oper leverag despit signific increas zebra increas year-over-
year ensur competit posit develop capabl adjac market despit
increas compani success increas adjust ebitda margin bp prior year
broad-bas product geograph growth region strong led north america
organ regard product mobil comput led way
tariff manag believ effect tariff small mitig compani
experi signific pre-buy ahead tariff expect
solid guidanc increas manag guid sale growth
compar consensu expect assum posit impact
acquisit xplore technolog neutral fx impact reiter ebitda margin
guid ep consensu estim like come
rais price result increas estim increas price target
rais ep estim
zebra financi result prove manag execut top bottom
line ad sizabl moat competitor catalyst zebra share continu
move higher numer includ android adopt transport logist
manufactur vertic synergi xplore technolog acquisit oper scale new
adjust ebitda margin guidanc rais outlook
zebra adjust ebitda margin basi point better basi point better
sequenti due strong sale expand gross margin increas oper leverag result
million adjust ebitda histor ebitda margin revenu growth shown exhibit
de-lever lead option creat sharehold wealth
zebra expect gener million free cash flow million increas prior
guidanc alreadi paid million debt first three quarter
allow zebra achiev leverag well within target leverag goal expect zebra
leverag year-end expect organ reinvest strateg first prioriti
near futur howev buyback potenti although unlik current share price
growth evm busi outpac segment grow organ basi respect
shown exhibit expect growth evm segment led strong mobil comput
sale robust android power portfolio data captur print solut also perform well
estim zebra new mobil comput sold android platform
compani note growth across region end market retail healthcar transport logist
manufactur manag believ manufactur pick market
begin refresh old window base product android
compani issu guidanc revenu growth impli revenu billion midpoint
compar consensu expect million go call guidanc includ neutral fx impact
ep guidanc well consensu expect prior call straddl
estim immedi call compani expect adjust ebitda margin
impli full-year expect increas end rang bp outlook
northcoast research compani filingszebra quarterli adjust ebitda marginexhibit ebitda marginy/i bp changey/i bp changeadjust ebitda margin northcoast research compani filingszebra quarterli revenu growthexhibit compani sale million y/i organ growthrevenueorgan growth/declin northcoast research compani filingszebra quarterli segment revenu growthexhibit printer sale million y/i organ growth revenu organ growth northcoast research compani filingszebra quarterli evm segment revenu growthexhibit enterpris sale million y/i organ growthevm revenueevm organ growth revenu impli report growth slightli top end rang given last quarter
includ posit impact acquisit xplore technolog neutral fx
rais revenu estim billion billion reflect organ growth
revenu estim may conserv go challeng comparison
ep estim increas increas due better expect sale increas
oper margin estim adjust ebitda margin maintain revenu
expect billion increas ep estim assum slightli greater
mix low margin larger deal well modest gross margin pressur tariff estim assum
zebra mitig impact tariff price increas assum neglig impact demand
robust economi product enhanc implement zebra solut make compel
argument custom move forward even face mild advers
reiter buy rate increas price target share
price target place multipl ep share trade ep estim
ev/ebitda basi price target place ntm ev/ebitda multipl zebra share
recent averag one justifi base zebra improv balanc sheet provid addit
flexibl well increas confid compani long-term busi model
quarterli earn model million
revenu
servic softwar
revenu
servic softwar
total sale
revenu
revenu
servic softwar margin
revenu
revenu
sell market
revenu
research develop
revenu
gener administr
revenu
amort intang asset
acquisiiton integr cost
revenu
revenu
revenu
revenu
revenu
revenu
quarterli earn model million
gaap net income/ loss continu op
acquisit integr cost
amort intang
amort debt issuanc cost
/loss interest rate swap
loss invest
tax impact adjust item
sale
chang non-gaap net incom
chang non-gaap ep
balanc sheet million
cash equival
prepaid expens asset
properti equip net
long term invest market secur
total asset
current portion long-term debt
accumul comprehens incom loss
total liabil sharehold equiti
million
flow oper activ
adjust reconcil net incom net cash
depreci amort
amort debt issuanc cost discount
excess tax benefit share-bas compens
loss forward interest rate swap
chang oper asset liabil net busi acquir
net asset
net accru expens current liabil
net cash provid oper activ
flow invest activ
purchas properti equip
proce sale asset
payment patent licens agreement
acquisit busi net cash acquir
purchas long-term invest
purchas invest market secur
sale invest
net cash use invest activ
flow financ activ
issuance/ paydown debt
payment debt issuanc cost
proce issuanc long-term debt
payment debt extinguish cost
proce stock option exercis
excess tax benefit share-bas compens
net cash use financ activ
effect exchang rate chang cash cash equival
net increas decreas cash cash equival
balanc discontinu oper begin period
cash equival begin period
cash equival end period
oper
